<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03417206</url>
  </required_header>
  <id_info>
    <org_study_id>SilesianMUKOAiIT9</org_study_id>
    <nct_id>NCT03417206</nct_id>
  </id_info>
  <brief_title>PRD-guided Analgesia During FESS for Intraoperative Blood Loss</brief_title>
  <acronym>FESSPRD</acronym>
  <official_title>Comparative Study of Influence of Total Intravenous Anaesthesia (TIVA) and Volatile Anaesthesia Using Sevoflurane or Desflurane on the Intraoperative Blood Loss During Functional Endoscopic Sinus Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Silesia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Silesia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this randomized trial is to assess the utility of Pupillary Dilatation Reflex
      (PRD) for monitoring pain perception intraoperatively and its influence on intraoperative
      blood loss, quality of surgical field using Boezaart Bleeding Scale (BBS) in patients
      undergoing functional sinus surgery (FESS) under total intravenous anaesthesia using propofol
      or volatile anaesthesia using sevoflurane or desflurane
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Intraoperative blood loss during FESS constitutes a major problem for a surgeon because it
      influences quality of surgical field. Each incident of haemorrhage makes the operator stop
      the procedure in order to bring back the optimal visualization of the intranasal anatomy. In
      the end it prolongs the time of procedure.

      Currently, intraoperative blood loss is estimated based on Boezaart Bleeding Scale (BBS) (0 -
      no bleeding (cadaveric conditions), 1 - Slight bleeding, no suctioning required, 2 - Slight
      bleeding, occasional suctioning required, 3 - Slight bleeding, frequent suctioning required;
      bleeding threatens surgical field a few seconds after suction is removed, 4 - Moderate
      bleeding, frequent suctioning required, and bleeding threatens surgical field directly after
      suction is removed, 5 - Severe bleeding, constant suctioning required; bleeding appears
      faster than can be removed by suction; surgical field severely threatened and surgery usually
      not possible).

      Recently, Pupillary Dilatation Reflex (PRD) was added as a surrogate variable showing the
      nociception-antinociception balance into above mentioned parameters constituting a novel
      approach in monitoring patients intraoperatively, known as adequacy of anaesthesia (AoA) or
      tailor-made anaesthesia. PRD value &gt;5% reflects increased sensitivity to painful stimulus it
      constitutes the indication for administration of rescue analgesia intraoperatively.

      This study aims at evaluating utility of PRD-directed analgesia using remifentanil on the
      intraoperative blood loss, haemodynamic stability and time duration of surgery in patients
      undergoing functional sinus surgery (FESS) under total intravenous anaesthesia using propofol
      or volatile anaesthesia using sevoflurane or desflurane Currently, FESS is most often
      performed using total intravenous anaesthesia (TIVA) which is by majority of
      anaesthesiologists believed to reduce the intraoperative blood loss compared to general
      anaesthesia using volatile anaesthetics, but current literature provides conflicting findings
      in this area if the sort of anaesthetic used influences quality of the surgical field.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2018</start_date>
  <completion_date type="Anticipated">January 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>blood loss postoperatively</measure>
    <time_frame>end of operation,' assessment</time_frame>
    <description>the investigators will measure the amount of blood loss in the suction bag in millilitres (ml) using a syringe after operation of FESS is completed</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>heart rate stability intraoperatively</measure>
    <time_frame>intraoperative assessment</time_frame>
    <description>the investigators will measure heart rate during TIVAevery 5 minutes up to the end of the operation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PRD-guided pain perception intraoperatively</measure>
    <time_frame>intraoperative assessment</time_frame>
    <description>The investigators will measure PRD value and adjust infusion speed of remifentanyl, in the case of PRD value &gt;5% the speed of remifentanyl infusion will accelerate by 50%, intraoperatively, every 15 minutes or at any change of BBS, up to the end of the operation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>condition of surgical field</measure>
    <time_frame>intraoperative assessment</time_frame>
    <description>the surgeon will assess the quality of surgical field using BBS when the operation of FESS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>total consumption of propofol</measure>
    <time_frame>end of operation assessment</time_frame>
    <description>The investigators will measure the consumption of propofol intraoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>total consumption of remifentanil</measure>
    <time_frame>end of operation assessment</time_frame>
    <description>The investigators will measure the consumption of remifentanyl intraoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>concentration of desflurane in end-expiratory gas</measure>
    <time_frame>intraoperative assessment</time_frame>
    <description>The investigators will measure theconcentration of desflurane in end-expiratory gas intraoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>concentration of sevoflurane in end-expiratory gas</measure>
    <time_frame>intraoperative assessment</time_frame>
    <description>The investigators will measure the concentration of sevoflurane in end-expiratory gas intraoperatively</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Endoscopic Sinus Surgery</condition>
  <arm_group>
    <arm_group_label>SEVOFLURANE INHALATIONAL ANAESTHESIA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>concentration of sevoflurane in the exhalation gas will be maintained to ensure target SE between 40, remifentanyl solution will be administered intravenously at a rate 0,25 mcg/kg of body weight/minute, intraoperatively PRD measurement every 15 minutes; when PRD&gt;5% infusion speed of remifentanyl will be increased by 50% every 5 minutes until PRD decreases below 5%</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DESFLURANE INHALATIONAL ANAESTHESIA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>concentration of desflurane in the exhalation gas will be maintained to ensure target SE 40, remifentanyl solution will be administered intravenously at a rate 0,25 mcg/kg of body weight/minute, intraoperatively PRD measurement every 15 minutes; when PRD&gt;5% infusion speed of remifentanyl will be increased by 50% every 5 minutes until PRD decreases below 5%</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TIVA USING PROPOROL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Infusion of propofol will be adjusted at target of SE 40,remifentanyl solution will be administered intravenously at a rate 0,25 mcg/kg of body weight/minute, intraoperatively PRD measurement every 15 minutes; when PRD&gt;5% infusion speed of remifentanyl will be increased by 50% every 5 minutes until PRD decreases below 5%</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remifentanil</intervention_name>
    <description>a rate of infusion will be increased by 50% every 5 minutes until PRD decreases below 5%</description>
    <arm_group_label>SEVOFLURANE INHALATIONAL ANAESTHESIA</arm_group_label>
    <arm_group_label>DESFLURANE INHALATIONAL ANAESTHESIA</arm_group_label>
    <arm_group_label>TIVA USING PROPOROL</arm_group_label>
    <other_name>Remifentanil infusion</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>pupillary dilatation reflex</intervention_name>
    <description>PRD value will me measured before the start of FESS after 5 minutes of remifentanyl infusion, when PRD sensitivity &gt; 5% , infusion of remifentanyl will be increased by 50% until PRD sensitivity &lt;5% and FESS will be started ; intraoperatively infusion of remifentanyl will be increased by 50% until PRD sensitivity &lt;5%</description>
    <arm_group_label>SEVOFLURANE INHALATIONAL ANAESTHESIA</arm_group_label>
    <arm_group_label>DESFLURANE INHALATIONAL ANAESTHESIA</arm_group_label>
    <arm_group_label>TIVA USING PROPOROL</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  - written consent to participate in the study

          -  written consent to undergo functional endoscopic sinus surgery under general
             anaesthesia

          -  ASA (American Society of Anesthesiologists) I-III

        Exclusion Criteria:

          -  age under 18 years old

          -  allergy to propofol

          -  pregnancy

          -  any anatomical malformation making PRD or SE measurement impossible
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Przemysław Jałowiecki, Ph. Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Silesia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michał J Stasiowski, MD</last_name>
    <phone>696797922</phone>
    <phone_ext>0048</phone_ext>
    <email>mstasiowski.anest@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lech Krawczyk, Ph. Dr</last_name>
    <phone>323682341</phone>
    <phone_ext>0048</phone_ext>
    <email>lech.kraw@gmail.com</email>
  </overall_contact_backup>
  <results_reference>
    <citation>Cafiero T, Cavallo LM, Frangiosa A, Burrelli R, Gargiulo G, Cappabianca P, de Divitiis E. Clinical comparison of remifentanil-sevoflurane vs. remifentanil-propofol for endoscopic endonasal transphenoidal surgery. Eur J Anaesthesiol. 2007 May;24(5):441-6. Epub 2007 Mar 12.</citation>
    <PMID>17376252</PMID>
  </results_reference>
  <results_reference>
    <citation>Sivaci R, Yilmaz MD, Balci C, Erincler T, Unlu H. Comparison of propofol and sevoflurane anesthesia by means of blood loss during endoscopic sinus surgery. Saudi Med J. 2004 Dec;25(12):1995-8.</citation>
    <PMID>15711683</PMID>
  </results_reference>
  <results_reference>
    <citation>Bhat Pai RV, Badiger S, Sachidananda R, Basappaji SM, Shanbhag R, Rao R. Comparison of surgical conditions following premedication with oral clonidine versus oral diazepam for endoscopic sinus surgery: A randomized, double-blinded study. J Anaesthesiol Clin Pharmacol. 2016 Apr-Jun;32(2):250-6. doi: 10.4103/0970-9185.182112.</citation>
    <PMID>27275059</PMID>
  </results_reference>
  <results_reference>
    <citation>Marzban S, Haddadi S, Mahmoudi Nia H, Heidarzadeh A, Nemati S, Naderi Nabi B. Comparison of surgical conditions during propofol or isoflurane anesthesia for endoscopic sinus surgery. Anesth Pain Med. 2013 Sep;3(2):234-8. doi: 10.5812/aapm.9891. Epub 2013 Sep 1.</citation>
    <PMID>24282774</PMID>
  </results_reference>
  <results_reference>
    <citation>Cardesín A, Pontes C, Rosell R, Escamilla Y, Marco J, Escobar MJ, Bernal-Sprekelsen M. Hypotensive anaesthesia and bleeding during endoscopic sinus surgery: an observational study. Eur Arch Otorhinolaryngol. 2014 Jun;271(6):1505-11. doi: 10.1007/s00405-013-2700-0. Epub 2013 Sep 20.</citation>
    <PMID>24052249</PMID>
  </results_reference>
  <results_reference>
    <citation>Cardesin A, Pontes C, Rosell R, Escamilla Y, Marco J, Escobar MJ, Bernal-Sprekelsen M. A randomised double blind clinical trial to compare surgical field bleeding during endoscopic sinus surgery with clonidine-based or remifentanil-based hypotensive anaesthesia. Rhinology. 2015 Jun;53(2):107-15. doi: 10.4193/Rhin14.185.</citation>
    <PMID>26030032</PMID>
  </results_reference>
  <results_reference>
    <citation>Drozdowski A, Sieśkiewicz A, Siemiatkowski A. [Reduction of intraoperative bleeding during functional endoscopic sinus surgery]. Anestezjol Intens Ter. 2011 Jan-Mar;43(1):45-50. Review. Polish.</citation>
    <PMID>21786531</PMID>
  </results_reference>
  <results_reference>
    <citation>Shen PH, Weitzel EK, Lai JT, Wormald PJ, Ho CS. Intravenous esmolol infusion improves surgical fields during sevoflurane-anesthetized endoscopic sinus surgery: a double-blind, randomized, placebo-controlled trial. Am J Rhinol Allergy. 2011 Nov-Dec;25(6):e208-11. doi: 10.2500/ajra.2011.25.3701.</citation>
    <PMID>22185726</PMID>
  </results_reference>
  <results_reference>
    <citation>Gomez-Rivera F, Cattano D, Ramaswamy U, Patel CB, Altamirano A, Man LX, Luong A, Chen Z, Citardi MJ, Fakhri S. Pilot study comparing total intravenous anesthesia to inhalational anesthesia in endoscopic sinus surgery: novel approach of blood flow quantification. Ann Otol Rhinol Laryngol. 2012 Nov;121(11):725-32.</citation>
    <PMID>23193905</PMID>
  </results_reference>
  <results_reference>
    <citation>Nekhendzy V, Lemmens HJ, Vaughan WC, Hepworth EJ, Chiu AG, Church CA, Brock-Utne JG. The effect of deliberate hypercapnia and hypocapnia on intraoperative blood loss and quality of surgical field during functional endoscopic sinus surgery. Anesth Analg. 2007 Nov;105(5):1404-9, table of contents.</citation>
    <PMID>17959973</PMID>
  </results_reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 5, 2018</study_first_submitted>
  <study_first_submitted_qc>January 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 31, 2018</study_first_posted>
  <last_update_submitted>April 23, 2018</last_update_submitted>
  <last_update_submitted_qc>April 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Silesia</investigator_affiliation>
    <investigator_full_name>Michał Stasiowski</investigator_full_name>
    <investigator_title>Principal Investigator, 2Department of Anaesthesiology and Intensive Therapy</investigator_title>
  </responsible_party>
  <keyword>Pupillary Dilatation Reflex (PRD)</keyword>
  <keyword>Intraoperative Blood Loss (IBL)</keyword>
  <keyword>Boezaart Bleeding Scale (BBS)</keyword>
  <keyword>Spectral Entropy (SE)</keyword>
  <keyword>Adequacy of Anaesthesia (AoA)</keyword>
  <keyword>Total Intravenous Anaesthesia (TIVA)</keyword>
  <keyword>Sevoflurane</keyword>
  <keyword>Desflurane</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
    <mesh_term>Desflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>article in Laryngoscope in 2022, case reports</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

